Skip to main content

"An Exciting Journey" - MCCA PhD Symposium and SFB F46 Closing Event


26. August 2019


Medizinische Universität Wien
Rektoratsgebäude (Bauteil 88), Ebene 2
Spitalgasse 23, 1090 Wien




Invitation Event zum Kalender hinzufügen (ICAL)


An Exciting Journey

Molecular, Cellular and Clinical Allergology (MCCA) PhD Symposium and SFB F46 'Towards prevention and therapy of allergy' Closing Event on Mechanisms of IgE-associated Diseases and Novel Approaches for the Therapy of Allergy and Beyond


Molecular, Cellular and Clinical Allergology (MCCA) is a doctoral program of the Medical University of Vienna and the Veterinary University of Vienna, Austria.

SFB F46 'Towards prevention and therapy of allergy' is a special research program located at the Medical University of Vienna and the Karl-Franzens-University of Graz, Austria.

Both programs are funded by the FWF Austrian Science Fund.




08:30 - 09:00 Registration

09:00 - 09:15 Opening

  • Michaela Fritz, Vice Rector for Research and Innovation, Medical University of Vienna
  • Winfried Pickl, MCCA Speaker
  • Rudolf Valenta, SFB Speaker

09:15 - 10:10 Session One

  • Mohamed Ridha Barbouche, Institut Pasteur de Tunis, Tunisia: Molecular dissection of and IgE specificities behind hyper-IgE syndromes
  • Sonja Kopanja, Medical University of Vienna: Soluble FceRI disrupts cell-bound chimeric IgE

10:10 - 11:05 Session Two

  • Ted Jardetzky, Stanford University, California, USA: On the contribution of IgE-receptors to the pathology of allergy
  • Sergio Villazala, Medical University of Vienna: The crosslinking ability of IgE-allergen complexes and the concentrations of specific IgE determine the extent of T cell activation mediated by CD23-FAP

11:05 - 11:30 Coffee Break

11:30 - 12:25 Session Three

  • Alain Jacquet, Chulalongkorn University, Bangkok, Thailand: How house dust mite allergens target the adaptive and innate immune system
  • Tanja Kalic, Medical University of Vienna: The role of tropomyosin in cross-reactivity between house dust mite and shellfish

12:25 - 14:45 Lunch Break and Guided Poster Session

14:45 - 15:40 Session Four

  • Christopher Paige, Princess Margaret Cancer Centre, Toronto, Canada: Interleukin-12 based modulation of (tumor-)immunity
  • Natalia Alkon, Medical University of Vienna: Innate lymphoid cells (ILCs) in skin and blood

15:40 - 16:05 Coffee Break

16:05 - 17:00 Session Five

  • Torsten Tonn, Medical Faculty Carl Gustav Carus, TU Dresden, Germany: In vivo eradication of malignant and non-malignant (autoreactive, allergen-specific) cell types by CAR technology
  • Peter Tauber, Medical University of Vienna: The kinase inhibitor BX-795 is a TCR signaling modulator that stimulates IL-2 while attenuating Th2 responses

17:00 Closing Remarks




Free admission!

Please register online via